Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer A Patient-Level Data Analysis of 3 Cohorts

- Kishan, Amar U., Steigler, Alison, Pilar, Avinash, Reddy, Chandana, Wedde, Trude B., Lilleby, Wolfgang A., Fiano, Ryan, Merrick, Gregory S., Stock, Richard G., Demanes, D. Jeffrey, Moran, Brian J., Tran, Phuoc T., Denham, James W., Martin, S, Martinez-Monge, R, Krauss, DJ, Abu-Isa, EI, Pisansky, TM, Choo, CR, Song, DY, Greco, S, Deville, C, McNutt, T, Zapatero, Almudena, DeWeese, TL, Ross, AE, Ciezki, JP, Tilki, D, Karnes, RJ, Tosoian, JJ, Nickols, NG, Bhat, P, Shabsovich, D, Juarez, JE, Guerrero, Araceli, Jiang, T, Ma, TM, Xiang, M, Philipson, R, Chang, A, Kupelian, PA, Rettig, MB, Feng, FY, Berlin, A, Tward, JD, Joseph, David, Davis, BJ, Reiter, RE, Steinberg, ML, Elashoff, D, Boutros, PC, Horwitz, EM, Tendulkar, RD, Spratt, DE, Romero, T, Maldonado, Xavier, Wong, Jessica K., Stish, Bradley J., Dess, Robert T.

Cost-effectiveness analysis of supervised exercise training in men with prostate cancer previously treated with radiation therapy and androgen-deprivation therapy

- Edmunds, Kim, Reeves, Penny, Tuffaha, Haitham, Scuffham, Paul, Galvão, Daniel A., Newton, Robert U., Jones, Mark, Spry, Nigel, Taaffe, Dennis R., Joseph, David, Chambers, Suzanne K.

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial

- Delahunt, Brett, Murray, Judith D., Samaratunga, Hemamali, Spry, Nigel A., Srigley, John R., Hondermarck, Hubert, Denham, James W., Steigler, Allison, Atkinson, Chris, Christie, David, Duchesne, Gillian, Egevad, Lars, Joseph, David, Matthews, John, Oldmeadow, Christopher

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial

- Joseph, David, Denham, James W., Turner, Sandra, Kenny, Lizbeth, Christie, David, Tai, Keen-Hun, Gogna, NirdoshK, Kearvell, Rachel, Murray, Judy, Ebert, Martin A., Haworth, Annette, Delahunt, Brett, Steigler, Allison, Oldmeadow, Christopher, Attia, John, Lamb, David S., Spry, Nigel A., Stanley, John, Shannon, Tom, Duchesne, Gillian, Atkinson, Chris, Matthews, John H. L.

Rectal and Urethro-Vesical Subregions for Toxicity Prediction After Prostate Cancer Radiation Therapy: Validation of Voxel-Based Models in an Independent Population

- Mylona, Eugenia, Ebert, Martin, Kennedy, Angel, Joseph, David, Denham, James, Steigler, Allison, Supiot, Stephane, Acosta, Oscar, de Crevoisier, Renaud

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

- Denham, James W., Joseph, David, Lamb, David S., Spry, Nigel A., Duchesne, Gillian, Matthews, John, Atkinson, Chris, Tai, Keen-Hun, Christie, David, Kenny, Lizbeth, Turner, Sandra, Gogna, Nirdosh Kumar, Diamond, Terry, Delahunt, Brett, Oldmeadow, Chris, Attia, John, Steigler, Allison

Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: Results from the TROG 03.04 RADAR trial

- Marcello, Marco, Ebert, Martin, Haworth, Annette, Steigler, Allison, Kennedy, Angel, Joseph, David, Denham, James

Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy

- Newton, Robert U., Jeffery, Emily, Galvão, Daniel A., Peddle-McIntyre, Carolyn J., Spry, Nigel, Joseph, David, Denham, James W., Taaffe, Dennis R.

Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases

- Galvão, Daniel A., Taaffe, Dennis R., Spry, Nigel, Cormie, Prue, Joseph, David, Chambers, Suzanne K., Chee, Raphael, Peddle-Mcintyre, Carolyn J., Hart, Nicolas H., Baumann, Freerk T., Denham, James, Baker, Michael, Newton, Robert U.

Postmastectomy radiation therapy in women with T1-T2 tumors and 1 to 3 positive lymph nodes: analysis of the Breast International Group 02-98 Trial

- Zeidan, Youssef, Habib, Joyce, Lluch, Ana, Gnant, Michael, Goldhirsch, Aron, Di Leo, Angelo, Joseph, David, Crown, John, Piccart-Gebhart, Martine, Francis, Prudence, Ameye, Lieveke, Paesmans, Marianne, de Azambuja, Evandro, Gelber, Richard, Campbell, Ian, Nordenskjold, Bo, Gutierez, Jorge, Anderson, Michael

Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer

- Taaffe, Dennis R., Buffart, Laurien M., Newton, Robert U., Spry, Nigel, Denham, James, Joseph, David, Lamb, David, Chambers, Suzanne K., Galvão, Daniel A.

Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial

- Sridharan, Swetha, Steigler, Allison, Attia, John, Holliday, Elizabeth G., Denham, James W., Spry, Nigel A., Joseph, David, Lamb, David S., Matthews, John H., Atkinson, Chris, Tai, Keen-Hun, Duchesne, Gillian, Christie, David

Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial

- Cormie, Prue, Galvão, Daniel A., Spry, Nigel, Joseph, David, Chee, Raphael, Taaffe, Dennis R., Chambers, Suzanne K., Newton, Robert U.

Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial

- Denham, James W., Steigler, Allison, Tai, Keen-Hun, Gogna, Nirdosh Kumar, Gill, Suki, Tan, Hendrick, Kearvell, Rachel, Murray, Judy, Ebert, Martin, Haworth, Annette, Kennedy, Angel, Delahunt, Brett, Joseph, David, Oldmeadow, Christopher, Holliday, Elizabeth G., Attia, John, Lamb, David S., Spry, Nigel A., Duchesne, Gillian, Atkinson, Chris, Matthews, John, Turner, Sandra, Kenny, Lizbeth

A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR

- Galvão, Daniel A., Spry, Nigel, Denham, James, Taaffe, Dennis R., Cormie, Prue, Joseph, David, Lamb, David S., Chambers, Suzanne K., Newton, Robert U.

Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: longitudinal results of a pilot study

- Cormie, Prue, Galvão, Daniel A., Spry, Nigel, Joseph, David, Taaffe, Dennis R., Newton, Robert U.

Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies

- Cormie, Prue, Chambers, Suzanne K., Hamilton, Kyra, Galvão, Daniel A., Newton, Robert U., Gardiner, Robert A., Spry, Nigel, Taaffe, Dennis R., Joseph, David, Hamid, M. Akhlil, Chong, Peter, Hughes, David

Maximal exercise testing of men with prostate cancer being treated with androgen deprivation therapy

- Wall, Bradley A., Galvão, Daniel A., Fatehee, Naeem, Taaffe, Dennis R., Spry, Nigel, Joseph, David, Newton, Robert U.

Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer

- Buffart, Laurien M., Galvão, Daniel A., Chinapaw, Mai J., Brug, Johannes, Taaffe, Dennis R., Spry, Nigel, Joseph, David, Newton, Robert U.

Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer

- Denham, James W., Steigler, Allison, Wynne, Chris, Lamb, David S., Tai, Keen-Hun, Joseph, David, Matthews, John, Atkinson, Chris, Spry, Nigel A., Turner, Sandra, North, John, Christie, David